Nabil Kaci

Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia

Florence Lorget, Nabil Kaci, Jeff Peng et al. · The American Journal of Human Genetics · 2012 · 199 citations · Full text

Regenerative Medicine, Therapeutic Potential, Cnp Analog +8

Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model

Davide Komla‐Ebri, Emilie Dambroise, Ina Krämer et al. · Journal of Clinical Investigation · 2016 · 106 citations · Full text

Fgfr3-related Dwarfism, Excessive Fgfr3 Activation, Developmental Biology +14

FGFR3 mutation causes abnormal membranous ossification in achondroplasia

Federico Di Rocco, Martin Biosse Duplan, Yann Heuzé et al. · Human Molecular Genetics · 2014 · 84 citations

Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia

Ludovic Martin, Nabil Kaci, Valentin Estibals et al. · Human Molecular Genetics · 2017 · 47 citations · Full text

Pathology, Cytoskeleton, Cell Growth +17

A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model

Aurélie Jonquoy, Emilie Mugniery, Catherine Benoist-Lasselin et al. · Human Molecular Genetics · 2011 · 46 citations · Full text